To assess the contribution of NK cells to DKK1-mediated tumor growth in vivo, we used the DKK1-expressing human prostate cancer cell line PC3 in a severe combined immunodeficient (SCID) mouse model. The gene discussed is DKK1; the disease is neoplasm.